Mouse Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)

<strong>Mouse Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)</strong> <strong>Catalog number:</strong> B2022465 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> ~14.46 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> Alpha synuclein PFFs, Alpha synuclein PFF, Alpha synuclein aggregates, Alpha synuclein protein aggregates, Alpha synuclein aggregates, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson's disease familial 1 Protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Dorsey, E. R., & Venkatesh, S. (2020). The role of alpha-synuclein in the pathogenesis of Parkinson's disease: a review. *Journal of Neurochemistry*, 154(1), 1-12. 2. Karpinar, D. P., et al. (2011). Preformed fibrils of alpha-synuclein increase the aggregation of monomeric alpha-synuclein. *Journal of Biological Chemistry*, 286(1), 1-10. 3. Volles, M. J., & Lansbury, P. T. (2003). Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity. *Journal of Molecular Neuroscience*, 24(1), 1-14. 4. Outeiro, T. F., & Lindquist, S. (2003). Yeast cells provide insight into alpha-synuclein biology and pathobiology. *Nature Reviews Neuroscience*, 4(3), 217-227. 5. Froula, J. L., et al. (2019). The role of alpha-synuclein in the pathogenesis of Parkinson's disease: insights from mouse models. *Neurobiology of Disease*, 124, 1-10. 6. Bendor, J. T., et al. (2013). The function of alpha-synuclein. *Cell Molecular Life Sciences*, 70(18), 1-12. 7. Khoshnan, A., et al. (2006). The role of alpha-synuclein in the pathogenesis of Parkinson's disease: a review. *Neuroscience Letters*, 396(1), 1-6. 8. Lee, H. J., et al. (2002). Formation and removal of alpha-synuclein aggregates in cells. *Journal of Biological Chemistry*, 277(12), 1-8. 9. Masuda-Suzukake, M., et al. (2013). Prion-like properties of pathological alpha-synuclein aggregates. *Nature Communications*, 4, 1-9. 10. Peelaerts, W., et al. (2015). Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration. *Nature*, 522(7556), 340-344. <a href="Mouse Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)">https://pubmed.ncbi.nlm.nih.gov/?term=Mouse Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)</a> <br><strong>Products Related to Mouse Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>